CDHSF(CDHSF)
CDHSF
No analyst ratings available
No analyst price targets available for CDHSF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $273M | $291M | $281M |
| Low | $261M | $265M | $262M |
| High | $285M | $312M | $298M |
| EBITDA Avg | $106M | $113M | $110M |
| Low | $102M | $103M | $102M |
| High | $111M | $122M | $116M |
| EBIT Avg | $81M | $86M | $83M |
| Low | $77M | $78M | $77M |
| High | $84M | $92M | $88M |
| Net Income Avg | $61M | $62M | $67M |
| Low | $56M | $57M | $61M |
| High | $66M | $67M | $72M |
| EPS Avg | $0.05 | $0.05 | $0.05 |
| Low | $0.04 | $0.04 | $0.05 |
| High | $0.05 | $0.05 | $0.06 |
| Analysts (Rev / EPS) | 10 / 1 | 10 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q1 2028 |
|---|---|---|---|---|
| Revenue Avg | $88M | $88M | $88M | $143M |
| Low | $88M | $88M | $88M | $143M |
| High | $88M | $88M | $88M | $143M |
| EBITDA Avg | $34M | $34M | $34M | $56M |
| Low | $34M | $34M | $34M | $56M |
| High | $34M | $34M | $34M | $56M |
| EBIT Avg | $26M | $26M | $26M | $42M |
| Low | $26M | $26M | $26M | $42M |
| High | $26M | $26M | $26M | $42M |
| Net Income Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| EPS Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — |